{"@odata.context":"/odata/553921bdf1072fd0dd637bfa82ca2548/7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba/%24metadata?ledger=553921bdf1072fd0dd637bfa82ca2548&snapshot=7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba#T_comorbidity_2026_08_22_citations_2e4f6e7dde49(pmid,title,journal,pubdate,first_author,doi,url,RowId)","@Coverage.AnalysisSkill":"/analysis.skill.txt?ledger=553921bdf1072fd0dd637bfa82ca2548&snapshot=7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba","@Coverage.Arrow":"/results/d289e7bbaf21a301586b4f307a8f347030ccd16141d691269517c38835cdfad9/data.arrow?ledger=553921bdf1072fd0dd637bfa82ca2548&snapshot=7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba","@Coverage.Receipt":"/receipts/r38/?ledger=553921bdf1072fd0dd637bfa82ca2548&snapshot=7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba","@Coverage.SavedResult":"/results/d289e7bbaf21a301586b4f307a8f347030ccd16141d691269517c38835cdfad9/?ledger=553921bdf1072fd0dd637bfa82ca2548&snapshot=7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba","@Coverage.Source":{"grain":"Packaged source record; inspect schema and linked world method before aggregation","id":"comorbidity/2026-08-22/citations","path":"data/comorbidity/2026-08-22/citations.parquet","source":"data/comorbidity/2026-08-22/citations.parquet","vintage":"Package vintage 2026-10-01; source path partition 2026-08-22; inspect record and rule clocks separately"},"value":[{"@odata.id":"/odata/553921bdf1072fd0dd637bfa82ca2548/7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba/T_comorbidity_2026_08_22_citations_2e4f6e7dde49%280%29?ledger=553921bdf1072fd0dd637bfa82ca2548&snapshot=7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba","RowId":0,"RowId@odata.type":"#Int64","doi":"10.1002/hep.28431","first_author":"Younossi ZM","journal":"Hepatology","pmid":"26707365","pubdate":"2016 Jul","title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.","url":"https://pubmed.ncbi.nlm.nih.gov/26707365/"},{"@odata.id":"/odata/553921bdf1072fd0dd637bfa82ca2548/7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba/T_comorbidity_2026_08_22_citations_2e4f6e7dde49%281%29?ledger=553921bdf1072fd0dd637bfa82ca2548&snapshot=7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba","RowId":1,"RowId@odata.type":"#Int64","doi":"10.1136/gutjnl-2020-322572","first_author":"Mantovani A","journal":"Gut","pmid":"32938692","pubdate":"2021 May","title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals.","url":"https://pubmed.ncbi.nlm.nih.gov/32938692/"},{"@odata.id":"/odata/553921bdf1072fd0dd637bfa82ca2548/7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba/T_comorbidity_2026_08_22_citations_2e4f6e7dde49%282%29?ledger=553921bdf1072fd0dd637bfa82ca2548&snapshot=7a53af6a9beb58928d4a64dc92db09c9db65433f9909f1a10d16e302adaf86ba","RowId":2,"RowId@odata.type":"#Int64","doi":"10.1016/S2468-1253(21)00308-3","first_author":"Mantovani A","journal":"Lancet Gastroenterol Hepatol","pmid":"34555346","pubdate":"2021 Nov","title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.","url":"https://pubmed.ncbi.nlm.nih.gov/34555346/"}]}